Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05643079

Medial Displacement Calcaneal Osteotomy and FDL- Transfer - With a Human, Allogeneic Cortical Bone Screw

The goal of this observational study is to compare the use of a screw made of human bone (Shark-Screw®, Surgebright-GmbH) with the metal/Bio-Tenodesis screw (Arthrex) in the treatment of the symptomatic flatfoot using the medializing calcaneus osteotomy with flexor digitorum longus transfer (FDL) in adult patients. The advantage of the human bone screw is that after surgery no hardware removal is necessary. The screw is transformed from the body to normal bone.

The main questions it aims to answer are:

* Can the human bone screw achieve union rates like the metal/Bio-Tenodesis screw? * Is the time to union similar between the different screws? * Is the complication rate similar between the different screws? * Are the activity scores American Orthopaedic Foot and Ankle Society (AOFAS), Foot and Ankle Outcome Score (FAOS) and Foot Function Index (FFI) after surgery similar in the compared patient groups?

Participants will have

* the surgery * follow-ups at 6 weeks, 6 months, 1 and 2 years. * X-rays are performed at each follow up. * CT-scans are performed after 6 months. * activity scores are collected at the follow up after 6 months, 1 year and 2 years.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Abteilung für Kinderorthopädie und Fußchirurgie Orthopädisches Spital Speising

Vienna, 1130, Austria

Location status: Recruiting

Location contact

Florian Wenzel-Schwarz, MD

CONTACT

[email protected]

+43180182 ext. 3081

Florian Wenzel-Schwarz, MD

PRINCIPAL_INVESTIGATOR

About this study

Symptomatic flatfoot deformity in adults often occurs as a result of dysfunction of the Tibialis posterior tendon (TPTD), with a prevalence of 3.3%. Structured non-surgical treatment programs with orthotics and physiotherapy can achieve a high level of long-term subjective and functional satisfaction, with surgery being avoided in 70-89% of cases. Surgical intervention is indicated for progressive or uncontrolled symptoms. Flexible flatfoot deformity, stage II classified by Johnson and Strom, can be treated with a joint-preserving strategy, which usually includes a medializing calcaneal osteotomy, debridement of the tibialis posterior tendon, and transfer of the flexor digitorum longus (FDL) tendon. 87% satisfaction after ten years was observed in both pain relief and foot function and alignment.

Metal screws have been used for decades to treat bone fractures. The removal is the major disadvantage of conventional osteosyntheses and requires a second operation, with all the resulting risks of complications for each patient. The use of the bone screw from allogeneic cortical bone would reduce costs substantially, with a significant reduction in the average complication rate to 0.3%.

The idea of stabilizing fractures using compact bone instead of metal is not new. Obwegeser published the clinical use of 796 screw implants of allogeneic bone and reported that the only complication was the fracture of 6 screws (<1%) and three screw loosening (<0,5%).

Since 2016, the human, allogeneic cortical bone screw(Shark Screw®) has been used by two tissue banks, the Austrian Austrian tissue bank Surgebright-GmbH and the German Institute for Cell and Tissue Replacement (DIZG). The Shark Screw® graft was approved by the competent Austrian authority (AGES) in 2016. The bone graft immediately creates a solid, purely bony connection. This leads to bone remodeling, bone incorporation and optimal reparation in the surgical area. Depending on the loads and requirements, the bone connection adapts for the future. The bone grafts undergo a certified sterilization procedure at the DIZG, which was developed in 1985 at the Berlin Charité.

Due to the lack of further systematic investigations to objectively confirm the theoretically given and subjectively experienced product advantages, this observational study is now being conducted.

The aim of the present study is to evaluate the application of the human allogeneic cortical bone screw (Shark Screw®) and the metal/Bio-Tenodesis screw in the surgical treatment (medializing calcaneus osteotomy with FDL transfer) of symptomatic flatfoot and to systematically document corresponding clinical and radiological parameters before and after surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Indication for the use of a metal/Bio-Tenodesis screw or human bone screw in medializing calcaneus osteotomy with FDL transfer.
  • BMI< 40 kg/m²

Exclusion criteria

  • Insufficient knowledge of German
  • Alcohol and drug abuse
  • Pregnant woman or nursing mother
  • Foreseeable compliance problems
  • Neoplastic diseases, malignant bone tumors, rheumatoid arthritis
  • Active osteomyelitis
  • History of foot surgery
  • Advanced osteoarthritis of the lower ankle joint
  • Ulcerations in the skin of the surgical area
  • Immunosuppressive medications that cannot be discontinued
  • BMI >40

Treatment and study plan

medializing calcaneal osteotomy and/or transfer of the flexor digitorum longus tendon (FDL) with metal/Bio-Tenodesis screws

Procedure

The calcaneus osteotomy is performed dorsal proximal to plantar distal with caution of the peroneal tendons and sural nerve. After mobilization the dorsal fragment is displaced medially by~10mm. Thereafter, a guide wire is placed from plantar-lateral into the ventral portion of the calcaneus under fluoroscopic control. After stab incision and length measurement, the osteotomy is fixed with a Metal/Bio-Tenodesis screw(MBS). The lateral projection of the edge is straightened. Opening of the tendon sheath of the FDL muscle and dissection distally to Henry's node. Settling of the tendon and arming with a "shuttle suture". Tendon diameter measurement. Place a guide wire at os naviculare directed from plantar to dorsal in 20°proximal guidance. Pull through the FDL tendon from plantar to dorsal and fixation with an MBS in 20°of pointed foot position and inversion with appropriate desired tension. The tendon is then sutured to the stump of the tibialis posterior tendon, retinaculum sutures.

Other names: Metal/Bio-Tenodesis screw intervention

medializing calcaneal osteotomy and/or transfer of the flexor digitorum longus tendon (FDL) with Shark Screws®

Procedure

The calcaneus osteotomy is performed dorsal proximal to plantar distal with caution of the peroneal tendons and sural nerve. After mobilization the dorsal fragment is displaced medially by approx.10mm. Thereafter, a guide wire is placed from plantar-lateral into the ventral portion of the calcaneus under fluoroscopic control. After stab incision and length measurement, the osteotomy is fixed with a Shark Screw®. The lateral projection of the edge is straightened. Opening of the tendon sheath of the FDL muscle and dissection distally to Henry's node. Settling of the tendon and arming with a "shuttle suture". Tendon diameter measurement. Place a guide wire at os naviculare directed from plantar to dorsal in 20°proximal guidance. Pull through the FDL tendon from plantar to dorsal and fixation with the Shark Screw® in 20°of pointed foot position and inversion with appropriate desired tension. The tendon is then sutured to the stump of the tibialis posterior tendon, retinaculum sutures.

Other names: Shark Screw® intervention

Primary outcomes

  1. x-ray qualitative evaluation of changes in bony union of calcaneus osteotomy

    Time frame: 6 weeks, 6 months, 1 year, 2 years

    bony union will be evaluated

  2. CT-scan qualitative evaluation of changes in bony union of calcaneus osteotomy

    Time frame: 6 months, 1 year

    bony union will be evaluated

Secondary outcomes

  1. changes in AOFAS score in comparison to presurgery

    Time frame: 6 months, 1 year and 2 years

    The American Orthopedic Foot and Ankle Score (AOFAS) units in percent (%), the higher the better

  2. changes in Foot and Ankle Outcome Score (FOAS) score in comparison to presurgery

    Time frame: 6 months, 1 year and 2 years

    Foot and Ankle Outcome Score units in percent (%), the higher the better

  3. changes in FFI score in comparison to presurgery

    Time frame: 6 months, 1 year and 2 years

    Foot Function Index units in percent (%), the higher the better

  4. changes in Vas-Pain score in comparison to presurgery

    Time frame: 6 weeks, 6 months, 1 year and 2 years

    Visual Analog Scale Pain Score values between 0 and 10, 0= no pain, 10 sever pain

  5. complications

    Time frame: during surgery, 6 weeks, 6 months, 1 year and 2 years

    Complications will be recorded during surgery and the kind of complication described, number of patients with complications are given

  6. reoperations

    Time frame: during surgery, 6 weeks, 6 months, 1 year and 2 years

    Reoperations will be recorded when needed and the kind of re-operation and number of patients with reoperations are given

  7. pseudoarthrosis

    Time frame: during surgery, 6 months, 1 year and 2 years

    Pseudarthrosis will be recorded at the follow up at 2 years and number of patients with Pseudarthrosis are given

Study contacts

Contact information is provided by the study sponsor or research team.

Florian Wenzel-Schwarz, MD

CONTACT

[email protected]

+43180182 ext. 3081

Sponsors and collaborators

Lead sponsor

Orthopedic Hospital Vienna Speising

Other

Registry information

Official study title

Medial Displacement Calcaneal Osteotomy and FDL- Transfer - a Prospective Comparative Study Between Metal/Bio-Tenodesis Screw (Arthrex) and the Human, Allogeneic Cortical Bone Screw (Shark Screw®️, Surgebright-GmbH)

Important dates

Study start
2022
Primary completion
2027
Study completion
2028
First posted
Dec 8, 2022
Registry last updated
Mar 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.